nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomilnacipran—CYP2C8—Tamoxifen—pancreatic cancer	0.0741	0.1	CbGbCtD
Levomilnacipran—CYP2C8—Erlotinib—pancreatic cancer	0.063	0.0854	CbGbCtD
Levomilnacipran—CYP2C19—Tamoxifen—pancreatic cancer	0.0622	0.0842	CbGbCtD
Levomilnacipran—CYP2C8—Fluorouracil—pancreatic cancer	0.0546	0.074	CbGbCtD
Levomilnacipran—ABCB1—Tamoxifen—pancreatic cancer	0.0502	0.068	CbGbCtD
Levomilnacipran—CYP2D6—Tamoxifen—pancreatic cancer	0.0473	0.064	CbGbCtD
Levomilnacipran—ABCB1—Gemcitabine—pancreatic cancer	0.0432	0.0585	CbGbCtD
Levomilnacipran—ABCB1—Erlotinib—pancreatic cancer	0.0427	0.0578	CbGbCtD
Levomilnacipran—CYP2D6—Erlotinib—pancreatic cancer	0.0402	0.0544	CbGbCtD
Levomilnacipran—ABCB1—Irinotecan—pancreatic cancer	0.0385	0.0522	CbGbCtD
Levomilnacipran—CYP3A4—Tamoxifen—pancreatic cancer	0.0301	0.0407	CbGbCtD
Levomilnacipran—ABCB1—Docetaxel—pancreatic cancer	0.0282	0.0382	CbGbCtD
Levomilnacipran—ABCB1—Sunitinib—pancreatic cancer	0.0281	0.0381	CbGbCtD
Levomilnacipran—CYP3A4—Erlotinib—pancreatic cancer	0.0256	0.0346	CbGbCtD
Levomilnacipran—CYP3A4—Irinotecan—pancreatic cancer	0.0231	0.0313	CbGbCtD
Levomilnacipran—ABCB1—Doxorubicin—pancreatic cancer	0.021	0.0285	CbGbCtD
Levomilnacipran—CYP2D6—Doxorubicin—pancreatic cancer	0.0198	0.0269	CbGbCtD
Levomilnacipran—CYP3A4—Docetaxel—pancreatic cancer	0.0169	0.0229	CbGbCtD
Levomilnacipran—CYP3A4—Sunitinib—pancreatic cancer	0.0168	0.0228	CbGbCtD
Levomilnacipran—CYP3A4—Doxorubicin—pancreatic cancer	0.0126	0.0171	CbGbCtD
Levomilnacipran—Insomnia—Fluorouracil—pancreatic cancer	0.000386	0.00147	CcSEcCtD
Levomilnacipran—Somnolence—Gemcitabine—pancreatic cancer	0.000386	0.00147	CcSEcCtD
Levomilnacipran—Migraine—Doxorubicin—pancreatic cancer	0.000385	0.00147	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000384	0.00147	CcSEcCtD
Levomilnacipran—Fatigue—Irinotecan—pancreatic cancer	0.000384	0.00147	CcSEcCtD
Levomilnacipran—Paraesthesia—Fluorouracil—pancreatic cancer	0.000383	0.00146	CcSEcCtD
Levomilnacipran—Pruritus—Sunitinib—pancreatic cancer	0.000382	0.00146	CcSEcCtD
Levomilnacipran—Breast disorder—Epirubicin—pancreatic cancer	0.000382	0.00146	CcSEcCtD
Levomilnacipran—Constipation—Irinotecan—pancreatic cancer	0.000381	0.00145	CcSEcCtD
Levomilnacipran—Dyspnoea—Fluorouracil—pancreatic cancer	0.00038	0.00145	CcSEcCtD
Levomilnacipran—Mental disorder—Docetaxel—pancreatic cancer	0.000379	0.00145	CcSEcCtD
Levomilnacipran—Somnolence—Fluorouracil—pancreatic cancer	0.000379	0.00145	CcSEcCtD
Levomilnacipran—Malnutrition—Docetaxel—pancreatic cancer	0.000377	0.00144	CcSEcCtD
Levomilnacipran—Decreased appetite—Gemcitabine—pancreatic cancer	0.000377	0.00144	CcSEcCtD
Levomilnacipran—Dyspepsia—Fluorouracil—pancreatic cancer	0.000375	0.00143	CcSEcCtD
Levomilnacipran—Nausea—Tamoxifen—pancreatic cancer	0.000375	0.00143	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000374	0.00143	CcSEcCtD
Levomilnacipran—Fatigue—Gemcitabine—pancreatic cancer	0.000374	0.00143	CcSEcCtD
Levomilnacipran—Constipation—Gemcitabine—pancreatic cancer	0.000371	0.00142	CcSEcCtD
Levomilnacipran—Nausea—Erlotinib—pancreatic cancer	0.000371	0.00142	CcSEcCtD
Levomilnacipran—Decreased appetite—Fluorouracil—pancreatic cancer	0.000371	0.00142	CcSEcCtD
Levomilnacipran—Diarrhoea—Sunitinib—pancreatic cancer	0.00037	0.00141	CcSEcCtD
Levomilnacipran—Dysgeusia—Docetaxel—pancreatic cancer	0.000369	0.00141	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000368	0.00141	CcSEcCtD
Levomilnacipran—Abdominal distension—Epirubicin—pancreatic cancer	0.000367	0.0014	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000364	0.00139	CcSEcCtD
Levomilnacipran—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000361	0.00138	CcSEcCtD
Levomilnacipran—Dry skin—Doxorubicin—pancreatic cancer	0.000358	0.00137	CcSEcCtD
Levomilnacipran—Dizziness—Sunitinib—pancreatic cancer	0.000357	0.00137	CcSEcCtD
Levomilnacipran—Angina pectoris—Epirubicin—pancreatic cancer	0.000356	0.00136	CcSEcCtD
Levomilnacipran—Breast disorder—Doxorubicin—pancreatic cancer	0.000353	0.00135	CcSEcCtD
Levomilnacipran—Abdominal pain—Irinotecan—pancreatic cancer	0.000352	0.00134	CcSEcCtD
Levomilnacipran—Body temperature increased—Irinotecan—pancreatic cancer	0.000352	0.00134	CcSEcCtD
Levomilnacipran—Vomiting—Sunitinib—pancreatic cancer	0.000344	0.00131	CcSEcCtD
Levomilnacipran—Body temperature increased—Gemcitabine—pancreatic cancer	0.000343	0.00131	CcSEcCtD
Levomilnacipran—Dysuria—Epirubicin—pancreatic cancer	0.000341	0.0013	CcSEcCtD
Levomilnacipran—Neutropenia—Epirubicin—pancreatic cancer	0.000341	0.0013	CcSEcCtD
Levomilnacipran—Rash—Sunitinib—pancreatic cancer	0.000341	0.0013	CcSEcCtD
Levomilnacipran—Dermatitis—Sunitinib—pancreatic cancer	0.00034	0.0013	CcSEcCtD
Levomilnacipran—Abdominal distension—Doxorubicin—pancreatic cancer	0.00034	0.0013	CcSEcCtD
Levomilnacipran—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000339	0.0013	CcSEcCtD
Levomilnacipran—Urticaria—Fluorouracil—pancreatic cancer	0.000339	0.00129	CcSEcCtD
Levomilnacipran—Headache—Sunitinib—pancreatic cancer	0.000339	0.00129	CcSEcCtD
Levomilnacipran—Syncope—Docetaxel—pancreatic cancer	0.000338	0.00129	CcSEcCtD
Levomilnacipran—Leukopenia—Docetaxel—pancreatic cancer	0.000338	0.00129	CcSEcCtD
Levomilnacipran—Pollakiuria—Epirubicin—pancreatic cancer	0.000337	0.00129	CcSEcCtD
Levomilnacipran—Body temperature increased—Fluorouracil—pancreatic cancer	0.000337	0.00129	CcSEcCtD
Levomilnacipran—Palpitations—Docetaxel—pancreatic cancer	0.000333	0.00127	CcSEcCtD
Levomilnacipran—Loss of consciousness—Docetaxel—pancreatic cancer	0.000331	0.00127	CcSEcCtD
Levomilnacipran—Weight decreased—Epirubicin—pancreatic cancer	0.00033	0.00126	CcSEcCtD
Levomilnacipran—Angina pectoris—Doxorubicin—pancreatic cancer	0.000329	0.00126	CcSEcCtD
Levomilnacipran—Hypersensitivity—Irinotecan—pancreatic cancer	0.000328	0.00125	CcSEcCtD
Levomilnacipran—Convulsion—Docetaxel—pancreatic cancer	0.000327	0.00125	CcSEcCtD
Levomilnacipran—Hypertension—Docetaxel—pancreatic cancer	0.000326	0.00124	CcSEcCtD
Levomilnacipran—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000323	0.00123	CcSEcCtD
Levomilnacipran—Chest pain—Docetaxel—pancreatic cancer	0.000321	0.00123	CcSEcCtD
Levomilnacipran—Nausea—Sunitinib—pancreatic cancer	0.000321	0.00123	CcSEcCtD
Levomilnacipran—Asthenia—Irinotecan—pancreatic cancer	0.000319	0.00122	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000319	0.00122	CcSEcCtD
Levomilnacipran—Urinary tract infection—Epirubicin—pancreatic cancer	0.000316	0.00121	CcSEcCtD
Levomilnacipran—Neutropenia—Doxorubicin—pancreatic cancer	0.000316	0.00121	CcSEcCtD
Levomilnacipran—Dysuria—Doxorubicin—pancreatic cancer	0.000316	0.00121	CcSEcCtD
Levomilnacipran—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000314	0.0012	CcSEcCtD
Levomilnacipran—Dry mouth—Docetaxel—pancreatic cancer	0.000314	0.0012	CcSEcCtD
Levomilnacipran—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000314	0.0012	CcSEcCtD
Levomilnacipran—Pollakiuria—Doxorubicin—pancreatic cancer	0.000312	0.00119	CcSEcCtD
Levomilnacipran—Asthenia—Gemcitabine—pancreatic cancer	0.000311	0.00119	CcSEcCtD
Levomilnacipran—Haematuria—Epirubicin—pancreatic cancer	0.00031	0.00119	CcSEcCtD
Levomilnacipran—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000308	0.00118	CcSEcCtD
Levomilnacipran—Pruritus—Gemcitabine—pancreatic cancer	0.000307	0.00117	CcSEcCtD
Levomilnacipran—Infection—Docetaxel—pancreatic cancer	0.000306	0.00117	CcSEcCtD
Levomilnacipran—Weight decreased—Doxorubicin—pancreatic cancer	0.000306	0.00117	CcSEcCtD
Levomilnacipran—Diarrhoea—Irinotecan—pancreatic cancer	0.000305	0.00116	CcSEcCtD
Levomilnacipran—Shock—Docetaxel—pancreatic cancer	0.000303	0.00116	CcSEcCtD
Levomilnacipran—Nervous system disorder—Docetaxel—pancreatic cancer	0.000302	0.00115	CcSEcCtD
Levomilnacipran—Pruritus—Fluorouracil—pancreatic cancer	0.000302	0.00115	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000301	0.00115	CcSEcCtD
Levomilnacipran—Tachycardia—Docetaxel—pancreatic cancer	0.0003	0.00115	CcSEcCtD
Levomilnacipran—Skin disorder—Docetaxel—pancreatic cancer	0.000299	0.00114	CcSEcCtD
Levomilnacipran—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000299	0.00114	CcSEcCtD
Levomilnacipran—Diarrhoea—Gemcitabine—pancreatic cancer	0.000297	0.00113	CcSEcCtD
Levomilnacipran—Dizziness—Irinotecan—pancreatic cancer	0.000294	0.00113	CcSEcCtD
Levomilnacipran—Anorexia—Docetaxel—pancreatic cancer	0.000293	0.00112	CcSEcCtD
Levomilnacipran—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000293	0.00112	CcSEcCtD
Levomilnacipran—Hepatitis—Epirubicin—pancreatic cancer	0.000292	0.00112	CcSEcCtD
Levomilnacipran—Diarrhoea—Fluorouracil—pancreatic cancer	0.000292	0.00111	CcSEcCtD
Levomilnacipran—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000291	0.00111	CcSEcCtD
Levomilnacipran—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000289	0.0011	CcSEcCtD
Levomilnacipran—Oedema peripheral—Epirubicin—pancreatic cancer	0.000288	0.0011	CcSEcCtD
Levomilnacipran—Hypotension—Docetaxel—pancreatic cancer	0.000288	0.0011	CcSEcCtD
Levomilnacipran—Haematuria—Doxorubicin—pancreatic cancer	0.000287	0.0011	CcSEcCtD
Levomilnacipran—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000287	0.0011	CcSEcCtD
Levomilnacipran—Urethral disorder—Epirubicin—pancreatic cancer	0.000286	0.00109	CcSEcCtD
Levomilnacipran—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000285	0.00109	CcSEcCtD
Levomilnacipran—Vomiting—Irinotecan—pancreatic cancer	0.000283	0.00108	CcSEcCtD
Levomilnacipran—Dizziness—Fluorouracil—pancreatic cancer	0.000282	0.00108	CcSEcCtD
Levomilnacipran—Rash—Irinotecan—pancreatic cancer	0.000281	0.00107	CcSEcCtD
Levomilnacipran—Dermatitis—Irinotecan—pancreatic cancer	0.00028	0.00107	CcSEcCtD
Levomilnacipran—Headache—Irinotecan—pancreatic cancer	0.000279	0.00107	CcSEcCtD
Levomilnacipran—Insomnia—Docetaxel—pancreatic cancer	0.000278	0.00106	CcSEcCtD
Levomilnacipran—Paraesthesia—Docetaxel—pancreatic cancer	0.000276	0.00106	CcSEcCtD
Levomilnacipran—Erythema multiforme—Epirubicin—pancreatic cancer	0.000276	0.00106	CcSEcCtD
Levomilnacipran—Vomiting—Gemcitabine—pancreatic cancer	0.000276	0.00105	CcSEcCtD
Levomilnacipran—Dyspnoea—Docetaxel—pancreatic cancer	0.000274	0.00105	CcSEcCtD
Levomilnacipran—Somnolence—Docetaxel—pancreatic cancer	0.000274	0.00105	CcSEcCtD
Levomilnacipran—Rash—Gemcitabine—pancreatic cancer	0.000273	0.00104	CcSEcCtD
Levomilnacipran—Dermatitis—Gemcitabine—pancreatic cancer	0.000273	0.00104	CcSEcCtD
Levomilnacipran—Eye disorder—Epirubicin—pancreatic cancer	0.000273	0.00104	CcSEcCtD
Levomilnacipran—Headache—Gemcitabine—pancreatic cancer	0.000272	0.00104	CcSEcCtD
Levomilnacipran—Flushing—Epirubicin—pancreatic cancer	0.000271	0.00104	CcSEcCtD
Levomilnacipran—Cardiac disorder—Epirubicin—pancreatic cancer	0.000271	0.00104	CcSEcCtD
Levomilnacipran—Vomiting—Fluorouracil—pancreatic cancer	0.000271	0.00104	CcSEcCtD
Levomilnacipran—Dyspepsia—Docetaxel—pancreatic cancer	0.000271	0.00104	CcSEcCtD
Levomilnacipran—Hepatitis—Doxorubicin—pancreatic cancer	0.00027	0.00103	CcSEcCtD
Levomilnacipran—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000269	0.00103	CcSEcCtD
Levomilnacipran—Rash—Fluorouracil—pancreatic cancer	0.000269	0.00103	CcSEcCtD
Levomilnacipran—Dermatitis—Fluorouracil—pancreatic cancer	0.000269	0.00103	CcSEcCtD
Levomilnacipran—Decreased appetite—Docetaxel—pancreatic cancer	0.000268	0.00102	CcSEcCtD
Levomilnacipran—Headache—Fluorouracil—pancreatic cancer	0.000267	0.00102	CcSEcCtD
Levomilnacipran—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000267	0.00102	CcSEcCtD
Levomilnacipran—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000266	0.00102	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000266	0.00102	CcSEcCtD
Levomilnacipran—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000266	0.00102	CcSEcCtD
Levomilnacipran—Fatigue—Docetaxel—pancreatic cancer	0.000265	0.00101	CcSEcCtD
Levomilnacipran—Angiopathy—Epirubicin—pancreatic cancer	0.000265	0.00101	CcSEcCtD
Levomilnacipran—Urethral disorder—Doxorubicin—pancreatic cancer	0.000265	0.00101	CcSEcCtD
Levomilnacipran—Nausea—Irinotecan—pancreatic cancer	0.000264	0.00101	CcSEcCtD
Levomilnacipran—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000263	0.00101	CcSEcCtD
Levomilnacipran—Constipation—Docetaxel—pancreatic cancer	0.000263	0.00101	CcSEcCtD
Levomilnacipran—Chills—Epirubicin—pancreatic cancer	0.000262	0.001	CcSEcCtD
Levomilnacipran—Nausea—Gemcitabine—pancreatic cancer	0.000258	0.000984	CcSEcCtD
Levomilnacipran—Mental disorder—Epirubicin—pancreatic cancer	0.000256	0.000978	CcSEcCtD
Levomilnacipran—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000256	0.000977	CcSEcCtD
Levomilnacipran—Malnutrition—Epirubicin—pancreatic cancer	0.000254	0.000972	CcSEcCtD
Levomilnacipran—Nausea—Fluorouracil—pancreatic cancer	0.000253	0.000968	CcSEcCtD
Levomilnacipran—Eye disorder—Doxorubicin—pancreatic cancer	0.000253	0.000965	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000252	0.000962	CcSEcCtD
Levomilnacipran—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000251	0.000959	CcSEcCtD
Levomilnacipran—Flushing—Doxorubicin—pancreatic cancer	0.000251	0.000959	CcSEcCtD
Levomilnacipran—Flatulence—Epirubicin—pancreatic cancer	0.000251	0.000958	CcSEcCtD
Levomilnacipran—Tension—Epirubicin—pancreatic cancer	0.00025	0.000954	CcSEcCtD
Levomilnacipran—Dysgeusia—Epirubicin—pancreatic cancer	0.000249	0.000952	CcSEcCtD
Levomilnacipran—Angiopathy—Doxorubicin—pancreatic cancer	0.000245	0.000937	CcSEcCtD
Levomilnacipran—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000244	0.000931	CcSEcCtD
Levomilnacipran—Abdominal pain—Docetaxel—pancreatic cancer	0.000243	0.00093	CcSEcCtD
Levomilnacipran—Body temperature increased—Docetaxel—pancreatic cancer	0.000243	0.00093	CcSEcCtD
Levomilnacipran—Chills—Doxorubicin—pancreatic cancer	0.000243	0.000927	CcSEcCtD
Levomilnacipran—Vision blurred—Epirubicin—pancreatic cancer	0.00024	0.000916	CcSEcCtD
Levomilnacipran—Mental disorder—Doxorubicin—pancreatic cancer	0.000237	0.000905	CcSEcCtD
Levomilnacipran—Malnutrition—Doxorubicin—pancreatic cancer	0.000235	0.000899	CcSEcCtD
Levomilnacipran—Agitation—Epirubicin—pancreatic cancer	0.000234	0.000893	CcSEcCtD
Levomilnacipran—Flatulence—Doxorubicin—pancreatic cancer	0.000232	0.000886	CcSEcCtD
Levomilnacipran—Tension—Doxorubicin—pancreatic cancer	0.000231	0.000883	CcSEcCtD
Levomilnacipran—Dysgeusia—Doxorubicin—pancreatic cancer	0.00023	0.000881	CcSEcCtD
Levomilnacipran—Syncope—Epirubicin—pancreatic cancer	0.000228	0.000872	CcSEcCtD
Levomilnacipran—Leukopenia—Epirubicin—pancreatic cancer	0.000228	0.00087	CcSEcCtD
Levomilnacipran—Hypersensitivity—Docetaxel—pancreatic cancer	0.000227	0.000866	CcSEcCtD
Levomilnacipran—Palpitations—Epirubicin—pancreatic cancer	0.000225	0.000859	CcSEcCtD
Levomilnacipran—Loss of consciousness—Epirubicin—pancreatic cancer	0.000224	0.000854	CcSEcCtD
Levomilnacipran—Vision blurred—Doxorubicin—pancreatic cancer	0.000222	0.000848	CcSEcCtD
Levomilnacipran—Asthenia—Docetaxel—pancreatic cancer	0.000221	0.000844	CcSEcCtD
Levomilnacipran—Convulsion—Epirubicin—pancreatic cancer	0.00022	0.000842	CcSEcCtD
Levomilnacipran—Hypertension—Epirubicin—pancreatic cancer	0.00022	0.000839	CcSEcCtD
Levomilnacipran—Pruritus—Docetaxel—pancreatic cancer	0.000218	0.000832	CcSEcCtD
Levomilnacipran—Chest pain—Epirubicin—pancreatic cancer	0.000217	0.000827	CcSEcCtD
Levomilnacipran—Agitation—Doxorubicin—pancreatic cancer	0.000216	0.000826	CcSEcCtD
Levomilnacipran—Anxiety—Epirubicin—pancreatic cancer	0.000216	0.000825	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000215	0.000822	CcSEcCtD
Levomilnacipran—Dry mouth—Epirubicin—pancreatic cancer	0.000212	0.000809	CcSEcCtD
Levomilnacipran—Syncope—Doxorubicin—pancreatic cancer	0.000211	0.000806	CcSEcCtD
Levomilnacipran—Leukopenia—Doxorubicin—pancreatic cancer	0.000211	0.000805	CcSEcCtD
Levomilnacipran—Diarrhoea—Docetaxel—pancreatic cancer	0.000211	0.000805	CcSEcCtD
Levomilnacipran—Palpitations—Doxorubicin—pancreatic cancer	0.000208	0.000795	CcSEcCtD
Levomilnacipran—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000207	0.00079	CcSEcCtD
Levomilnacipran—Infection—Epirubicin—pancreatic cancer	0.000206	0.000788	CcSEcCtD
Levomilnacipran—Shock—Epirubicin—pancreatic cancer	0.000204	0.00078	CcSEcCtD
Levomilnacipran—Convulsion—Doxorubicin—pancreatic cancer	0.000204	0.000779	CcSEcCtD
Levomilnacipran—Nervous system disorder—Epirubicin—pancreatic cancer	0.000204	0.000778	CcSEcCtD
Levomilnacipran—Dizziness—Docetaxel—pancreatic cancer	0.000203	0.000778	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000203	0.000777	CcSEcCtD
Levomilnacipran—Hypertension—Doxorubicin—pancreatic cancer	0.000203	0.000776	CcSEcCtD
Levomilnacipran—Tachycardia—Epirubicin—pancreatic cancer	0.000203	0.000774	CcSEcCtD
Levomilnacipran—Skin disorder—Epirubicin—pancreatic cancer	0.000202	0.000771	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000201	0.000767	CcSEcCtD
Levomilnacipran—Chest pain—Doxorubicin—pancreatic cancer	0.0002	0.000766	CcSEcCtD
Levomilnacipran—Anxiety—Doxorubicin—pancreatic cancer	0.0002	0.000763	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000199	0.00076	CcSEcCtD
Levomilnacipran—Anorexia—Epirubicin—pancreatic cancer	0.000198	0.000756	CcSEcCtD
Levomilnacipran—Dry mouth—Doxorubicin—pancreatic cancer	0.000196	0.000749	CcSEcCtD
Levomilnacipran—Vomiting—Docetaxel—pancreatic cancer	0.000196	0.000748	CcSEcCtD
Levomilnacipran—Rash—Docetaxel—pancreatic cancer	0.000194	0.000742	CcSEcCtD
Levomilnacipran—Hypotension—Epirubicin—pancreatic cancer	0.000194	0.000741	CcSEcCtD
Levomilnacipran—Dermatitis—Docetaxel—pancreatic cancer	0.000194	0.000741	CcSEcCtD
Levomilnacipran—Headache—Docetaxel—pancreatic cancer	0.000193	0.000737	CcSEcCtD
Levomilnacipran—Infection—Doxorubicin—pancreatic cancer	0.000191	0.000729	CcSEcCtD
Levomilnacipran—Shock—Doxorubicin—pancreatic cancer	0.000189	0.000722	CcSEcCtD
Levomilnacipran—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000188	0.00072	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000188	0.000719	CcSEcCtD
Levomilnacipran—Insomnia—Epirubicin—pancreatic cancer	0.000188	0.000717	CcSEcCtD
Levomilnacipran—Tachycardia—Doxorubicin—pancreatic cancer	0.000187	0.000716	CcSEcCtD
Levomilnacipran—Skin disorder—Doxorubicin—pancreatic cancer	0.000187	0.000713	CcSEcCtD
Levomilnacipran—Paraesthesia—Epirubicin—pancreatic cancer	0.000186	0.000712	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000186	0.00071	CcSEcCtD
Levomilnacipran—Dyspnoea—Epirubicin—pancreatic cancer	0.000185	0.000707	CcSEcCtD
Levomilnacipran—Somnolence—Epirubicin—pancreatic cancer	0.000185	0.000705	CcSEcCtD
Levomilnacipran—Anorexia—Doxorubicin—pancreatic cancer	0.000183	0.0007	CcSEcCtD
Levomilnacipran—Nausea—Docetaxel—pancreatic cancer	0.000183	0.000699	CcSEcCtD
Levomilnacipran—Dyspepsia—Epirubicin—pancreatic cancer	0.000183	0.000698	CcSEcCtD
Levomilnacipran—Decreased appetite—Epirubicin—pancreatic cancer	0.00018	0.00069	CcSEcCtD
Levomilnacipran—Hypotension—Doxorubicin—pancreatic cancer	0.000179	0.000686	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000179	0.000685	CcSEcCtD
Levomilnacipran—Fatigue—Epirubicin—pancreatic cancer	0.000179	0.000684	CcSEcCtD
Levomilnacipran—Constipation—Epirubicin—pancreatic cancer	0.000177	0.000678	CcSEcCtD
Levomilnacipran—Insomnia—Doxorubicin—pancreatic cancer	0.000174	0.000664	CcSEcCtD
Levomilnacipran—Paraesthesia—Doxorubicin—pancreatic cancer	0.000172	0.000659	CcSEcCtD
Levomilnacipran—Dyspnoea—Doxorubicin—pancreatic cancer	0.000171	0.000654	CcSEcCtD
Levomilnacipran—Somnolence—Doxorubicin—pancreatic cancer	0.000171	0.000653	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.00017	0.000649	CcSEcCtD
Levomilnacipran—Dyspepsia—Doxorubicin—pancreatic cancer	0.000169	0.000646	CcSEcCtD
Levomilnacipran—Decreased appetite—Doxorubicin—pancreatic cancer	0.000167	0.000638	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000166	0.000634	CcSEcCtD
Levomilnacipran—Fatigue—Doxorubicin—pancreatic cancer	0.000166	0.000633	CcSEcCtD
Levomilnacipran—Urticaria—Epirubicin—pancreatic cancer	0.000165	0.00063	CcSEcCtD
Levomilnacipran—Constipation—Doxorubicin—pancreatic cancer	0.000164	0.000628	CcSEcCtD
Levomilnacipran—Abdominal pain—Epirubicin—pancreatic cancer	0.000164	0.000627	CcSEcCtD
Levomilnacipran—Body temperature increased—Epirubicin—pancreatic cancer	0.000164	0.000627	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000157	0.0006	CcSEcCtD
Levomilnacipran—Hypersensitivity—Epirubicin—pancreatic cancer	0.000153	0.000584	CcSEcCtD
Levomilnacipran—Urticaria—Doxorubicin—pancreatic cancer	0.000153	0.000583	CcSEcCtD
Levomilnacipran—Body temperature increased—Doxorubicin—pancreatic cancer	0.000152	0.00058	CcSEcCtD
Levomilnacipran—Abdominal pain—Doxorubicin—pancreatic cancer	0.000152	0.00058	CcSEcCtD
Levomilnacipran—Asthenia—Epirubicin—pancreatic cancer	0.000149	0.000569	CcSEcCtD
Levomilnacipran—Pruritus—Epirubicin—pancreatic cancer	0.000147	0.000561	CcSEcCtD
Levomilnacipran—Diarrhoea—Epirubicin—pancreatic cancer	0.000142	0.000543	CcSEcCtD
Levomilnacipran—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000141	0.000541	CcSEcCtD
Levomilnacipran—Asthenia—Doxorubicin—pancreatic cancer	0.000138	0.000527	CcSEcCtD
Levomilnacipran—Dizziness—Epirubicin—pancreatic cancer	0.000137	0.000525	CcSEcCtD
Levomilnacipran—Pruritus—Doxorubicin—pancreatic cancer	0.000136	0.000519	CcSEcCtD
Levomilnacipran—Vomiting—Epirubicin—pancreatic cancer	0.000132	0.000504	CcSEcCtD
Levomilnacipran—Diarrhoea—Doxorubicin—pancreatic cancer	0.000131	0.000502	CcSEcCtD
Levomilnacipran—Rash—Epirubicin—pancreatic cancer	0.000131	0.0005	CcSEcCtD
Levomilnacipran—Dermatitis—Epirubicin—pancreatic cancer	0.000131	0.0005	CcSEcCtD
Levomilnacipran—Headache—Epirubicin—pancreatic cancer	0.00013	0.000497	CcSEcCtD
Levomilnacipran—Dizziness—Doxorubicin—pancreatic cancer	0.000127	0.000485	CcSEcCtD
Levomilnacipran—Nausea—Epirubicin—pancreatic cancer	0.000123	0.000471	CcSEcCtD
Levomilnacipran—Vomiting—Doxorubicin—pancreatic cancer	0.000122	0.000467	CcSEcCtD
Levomilnacipran—Rash—Doxorubicin—pancreatic cancer	0.000121	0.000463	CcSEcCtD
Levomilnacipran—Dermatitis—Doxorubicin—pancreatic cancer	0.000121	0.000462	CcSEcCtD
Levomilnacipran—Headache—Doxorubicin—pancreatic cancer	0.00012	0.00046	CcSEcCtD
Levomilnacipran—Nausea—Doxorubicin—pancreatic cancer	0.000114	0.000436	CcSEcCtD
